A carregar...

Clinical predictors of extrapyramidal symptoms associated with aripiprazole augmentation for the treatment of late-life depression in a randomized controlled trial

OBJECTIVE: Augmentation with aripiprazole is an effective pharmacotherapy for treatment resistant late-life depression (TRLLD). However, aripirprazole can cause extrapyramidal symptoms (EPS) such as akathisia and parkinsonism; these symptoms are distressing and can contribute to treatment discontinu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychiatry
Main Authors: Hsu, Jonathan H., Mulsant, Benoit H., Lenze, Eric J., Sanches, Marcos, Karp, Jordan F., Reynolds, Charles F., Blumberger, Daniel M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6996023/
https://ncbi.nlm.nih.gov/pubmed/29924506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.17m11764
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!